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   ABSTRACT 
We describe a discrete event simulation model of tubercu-
losis (TB) and HIV disease, parameterized to describe the 
dual epidemics in Harare, Zimbabwe. TB and HIV are the 
leading causes of death from infectious disease among 
adults worldwide and the number of TB cases has risen 
significantly since the start of the HIV epidemic, particu-
larly in Sub-Saharan Africa, where the HIV epidemic is 
most severe. There is a need to devise new strategies for 
TB control in countries with a high prevalence of HIV. 
This model has been designed to investigate strategies for 
reducing TB transmission by more efficient TB case detec-
tion. The model structure and its validation are discussed. 
1 INTRODUCTION 
Tuberculosis (TB) and HIV are the leading causes of death 
from infectious diseases among adults (Corbett et al. 2003; 
World Health Organization 1999). Estimates for 2003 put 
the number of incident TB cases at 8.8 million, up from an 
estimated 8.3 million in 2000, with HIV being the main 
driving force (World Health Organization 2003). Adult 
HIV prevalence rates are now 20% or higher in six South-
ern African countries.  In these countries TB case notifica-
tion rates have increased 2 to 5 fold since 1990 and now 
between 460 and 720 people develop active TB disease per 
100,000 of population per year (World Health Organiza-
tion 2003).  
The international standard for TB control is the World 
Health Organization’s DOTS strategy (World Health Or-
ganization 2003), which aims to reduce the transmission of 
M. tuberculosis infection through prompt diagnosis and ef-
fective treatment of symptomatic TB patients who present 
at health care facilities, termed passive case-finding. Con-
siderable progress was made during the last decade using 
this strategy in countries with small HIV epidemics but the 
effect of HIV on the African TB epidemic outweighs the 
gains being made in other regions. 
In this paper we describe a discrete event simulation 
model that is being developed to evaluate the effects of 
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case-finding) for TB control in a high HIV prevalence set-
ting. In essence, active case-finding  involves targeted test-
ing of the population for active disease with one commonly 
used strategy being to target household members of TB pa-
tients. Those found to have active disease can be treated 
promptly, reducing the time spent with infectious TB and 
so cutting transmission rates. The current policy is that ac-
tive case-finding for adults living in endemic TB settings is 
ineffective, because transmission events between casual 
contacts greatly outnumber household transmission events 
(Rieder 2003). This policy was developed in an era of low 
HIV prevalence and the impact of the HIV epidemic on the 
relative importance of household versus community trans-
mission has not been fully assessed. The HIV epidemic 
will have some effect on transmission because the duration 
of infectiousness of HIV-related TB is much briefer than in 
HIV-negative TB patients (Corbett et al. 2004; Corbett et 
al. 2005). 
The end goal of the modeling is a geospatial, discrete 
event simulation (DES) model of TB transmission in the 
district, which will allow a full assessment of the effective-
ness of contact-tracing and case-finding strategies that 
make use of geographical information. The first stage, 
which we describe in this paper, is a DES model that sim-
ply differentiates between within-household transmission 
and random transmission of TB. Differentiating between 
these two modes of transmission is important as household 
transmission of M. tuberculosis has long been recognized 
as having very different dynamics from that in the wider 
community.  Household exposure to infectious TB carries 
a high risk of infection (25 to 50%) (Rieder 2003) while 
random transmission occurs at a lower background rate of 
approximately 0.5 to 1% per year (Dye et al. 1999). 
The model will be fitted to data from a large popula-
tion-based trial in Harare, Zimbabwe, DETECTB, which 
will become available during 2006. Data is being collected 
on the size and location of every household in the study 
area, as well as the number of inhabitants, their ages and 
their TB and HIV status.  When the baseline data are avail-
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able, we will use them to inform the model structure and 
parameters.  
In the work presented here, the model has been param-
eterized so that it corresponds with earlier deterministic 
models of TB and HIV (Vynnycky and Fine 1997; Currie 
et al. 2003). Validation of its output has been achieved by 
comparison with country-wide statistics for Zimbabwe 
(World Health Organization 2006; HIV data). In the future, 
the output will be validated using the results of follow up 
surveys that are to be carried out in the same study area 
every 6 months until the end of 2008. 
We discuss earlier models of TB and HIV in section 2 
and also give some of the necessary background biology to 
tuberculosis. In Section 3, we describe the model  in some 
detail, before going on to describe the validation process in 
Section 4 . We conclude and discuss our plans for future 
work in Section 5. 
2 BACKGROUND 
2.1 Literature 
The majority of previous studies have used deterministic 
compartment models (Blower 1996, 1998, Murray and 
Salomon 1998a, 1998b, Dye et al. 1998, Currie et al. 2003, 
2005, Williams et al. 2005). Deterministic compartmental 
models are when the population is divided into different 
epidemiological states and the movements between the 
states are represented by a system of differential equations. 
These previous compartmental models have focused on 
modeling TB at the population level. The studies concen-
trated on the effect of interventions at a large scale and al-
though many of them addressed the implications of reduc-
ing transmission, none of them were able to look at the 
actual mechanics behind it. These studies have been vital 
in understanding and quantifying TB disease progression 
in populations and will be used to inform our model. How-
ever it is felt that a discrete event simulation is more ap-
propriate for investigating interventions at the household 
level and enables the more intricate details of transmission 
to be understood. 
The importance of household versus random transmis-
sion has previously been studied using a deterministic 
compartment model developed to look at the importance of 
cluster size in TB disease dynamics (Aparicio et al. 2000, 
Song et al. 2002). Whilst this analysis was useful in under-
standing the impact of the evolution of TB virulence on TB 
dynamics, some aspects of the modeling were unrealistic 
and, critically, the population structure was ignored. The 
study also did not incorporate the effect of HIV.  
Murray (Murray 2002) is the only example that we are 
aware of where discrete event simulation has been used to 
model TB. She used her model to investigate the clustering 
of different strains of TB. The use of this technique was 460successful and modeling TB at the individual level proved 
to be a powerful tool. 
2.2 Tuberculosis  
A person infected with Mycobacterium tuberculosis (mTB) 
bacilli may have a latent infection or active TB disease. If 
the infection is latent, the mTB bacilli are present in the 
body but that they are not active because the immune sys-
tem has successfully “walled them off”. A person can re-
tain a latent infection for many years and the infection of-
ten only develops into active TB disease when the immune 
system is weakened. The most common form of TB dis-
ease is pulmonary TB, which affects the lungs. Other 
forms of TB disease are referred to as extra-pulmonary 
disease and could affect the central nervous system, bones, 
joints and the lymphatic system. TB skin sores can develop 
when an infected lymph gland bursts, but this is very un-
common. TB is only infectious if the disease is in the lungs 
or if a TB skin sore is left uncovered. In this study, we 
concentrate on pulmonary TB as a means of TB transmis-
sion.  
3 THE MODEL 
The TB model is a discrete event simulation model which 
allows the population to belong to six epidemiological 
classes, dependent on TB status. Movements through the 
pathways of the model are determined by an individual’s 
attributes (age, gender, HIV status), with the distributions  
used to describe progression currently based on the medi-
cal literature. As data from the Harare survey become 
available, some of these distributions will be changed to 
reflect the survey results. 
 Transmission is currently modeled  under the assump-
tion that the majority of transmissions will occur outside of 
the household with only one household transmission occur-
ring within the household per infectious person, per year 
(Rieder 2003). The numbers of each type of transmission 
event caused by an infectious person per year are therefore 
generated from Poisson distributions with means of  9 and 
1 respectively. When a transmission event is generated, an 
individual will be selected at random to become infected. If 
transmission is within household, the individual to be in-
fected will be selected from within the household, and if 
the transmission is outside the household, any member of 
the model population could become infected. Persons who 
have previously recovered from TB; or already have a la-
tent infection can be “reinfected” with mTB bacilli.  
 The model uses a schedule of events that are executed 
in chronological order. Any new events that are created are 
inserted into the correct position on the schedule, which is 
held as a linked list. For example, when a person is born, 
their time of natural death is generated and this “Natural 
Death” event is scheduled onto the event list. If the indi-
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vidual develops active TB disease and does not receive 
treatment before dying from TB, a new event, “Death from 
TB” will be scheduled at the appropriate time. If death 
from TB is scheduled to occur before their “Natural Death” 
event, the “Natural Death” event will be removed from the 
event list. 
3.1 Modeling the Natural History of TB 
The schematic for the model is given in Figure 1. Death 
can occur from any state, and death rates are higher for in-
dividuals with active disease. The structure is similar to 
that used for deterministic compartmental models in earlier 
studies (Debanne et al. 2000, Vynnycky 1996, Murray and 
Salomon 1998, Williams 2005 and Currie et al. 2005). We 
assume that the TB disease progression parameters for 
HIV-positive individuals only change when the individuals 
enter late-stage HIV, defined to be World Health Organiza-
tion stages 3 and above, approximately 6 years after infec-
tion (Morgan et al. 2002, World Health Organization 
1990). 
 Susceptible individuals are not infected with mTB. 
When they become infected, they enter the latent infection 
class. Individuals will then follow one of two routes: de-
velop active disease within 5 years, termed fast progression 
to active disease; or retain a latent mTB infection, pro-
gressing to active disease at a rate of 0.001 per year for 
HIV negatives (Sutherland 1947, Horwitz et al. 1969, Bar-
nett et al. 1971, Styblo 1991, Vynnycky 1996, Vynnycky 
and Fine 1997) and 0.1 per year for late-stage HIV-
positives (Schulzer et al. 1992, Williams et al. 2005).  Ap-
proximately 14% of HIV-negatives will exhibit fast pro-
gression (Sutherland 1968, Ferebee 1970, Comstock 1982, 
Sutherland et al. 1947, Styblo 1986, Krishnamurthy et al. 
1976, 1990, Vynnycky and Fine 1997) and 67% of indi-
viduals in late-stage HIV (Di Perri et al. 1989, Daley et al. 
1992, Edlin et al. 1992, Coronando et al. 1993). 
 Previous infection with mTB confers some immunity 
to developing active disease following reinfection with 
mTB. Only 4.9% of HIV-negatives  and 50% of late-stage 
HIV-positives (World Health Organization stages 3 and 
above) who are reinfected with mTB will follow fast pro-
gression to active disease (Currie et al. 2005).  
 Active TB disease can be infectious or non infectious, 
with 46% of individuals (30% of late-stage HIV-positives) 
developing infectious disease (Williams et al. 2005). Non 
infectious individuals are able to convert to infectious TB 
at rate 0.015 per year (Williams et al. 2005). When an in-
dividual develops active disease they will either be treated, 
and move to the “Treated” class, or they will die. The av-
erage time until treatment is 2 years (Currie et al. 2005) 
and the average time until death from TB is sampled from 
a Weibull distribution with mean of 3.3 years for infectious 
disease and 5 years for non infectious disease (Williams et 
al. 2005). For those with infectious disease, the time until 46death or treatment determines an individual’s duration of 
infectiousness, which in turn determines how many people 
the individual is likely to infect. We assume that individu-
als will transmit to an average of 10 other people per year 
(Currie et al. 2005). Children under fifteen rarely develop 
active TB disease but will retain a latent infection if in-
fected with mTB bacilli.  
 
 
 
 
Figure 1: Schematic of the discrete event simulation tuber-
culosis (TB) model. Death may occur from any state, but 
death rates are higher from active disease states. 
  
 The duration of treatment is assumed to be 6 months, 
at the end of which the individual will either fail or suc-
cessfully complete treatment. Those that successfully com-
plete the treatment course become “recovered” and those 
that fail will return to active disease. When a person has 
recovered they are again susceptible to reinfection from an 
infectious person, although they have an increased immu-
nity compared to the “susceptible” population. 
3.2 Model Initialization 
The simulation generates a population of 10,000 people us-
ing the age structure and life expectancy data from the 
WHO life tables. The individuals are assigned to house-
holds with an average household size of 5.5 (Action Aid 
International 2005) . The initial distribution of the popula-
tion amongst the epidemiological classes is obtained from 
the steady state output of  a deterministic compartmental 1
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model with the same structure as the DES model but no 
HIV epidemic. The compartmental model was developed 
using Berkeley Madonna, <http://www.berkeley 
madonna.com>. A warm up of approximately 300 years 
is then used before HIV is introduced. 
3.3 Modeling HIV 
We do not model HIV transmission explicitly but instead 
use a static model of HIV to generate a number of HIV in-
fections in each time step. Reasonably good data are avail-
able for the proportion of the population infected with 
HIV, termed the HIV prevalence, over time in the coun-
tries of interest. This is generally measured by HIV-testing 
women attending antenatal clinics. The future course of the 
epidemic is much less certain, however, making it desir-
able to use a flexible model to describe the HIV epidemic, 
giving us the opportunity to consider scenarios in which 
HIV prevalence increases, decreases or remains constant in 
the future.  
 The model we use was first introduced by Salomon 
and Murray (Salomon and Murray 2001) and acts to derive 
estimates of the HIV prevalence from a given HIV inci-
dence. The basic assumption is that the HIV prevalence in 
a time period is equal to the sum of the people who have 
previously been infected with HIV minus those who have 
died. Using this model, the prevalence at time t is given by, 
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where F(t) is the probability of surviving t time periods and 
Inc(i) is the HIV incidence in time period i. We use a 
Weibull function to describe the time from infection to 
death, matching that used in the simulation model. We as-
sume that HIV incidence follows a gamma distribution 
with a multiplicative factor γ to allow for differences in 
scale, and an additive term that is used to describe the 
long-term incidence, 
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for t > t0 + β(α - 1). This matches the function used in 
Salomon and Murray 2001. 
 
The variables α and β set the shape of the incidence curve, 
γ sets the scale of the curve and θ sets the level of the long-
term incidence, which is equal to θ multiplied by the peak 
incidence. The parameter θ can be used to define the sce-
nario for long-term behavior. Here, we assume θ equals 1, 
i.e. that the long-term HIV incidence is constant at the peak 
value, and fit the HIV model to HIV prevalence data from 462Zimbabwe <www.unaids.org> by varying the parame-
ters α, β and γ. We assume that the HIV prevalence data 
points have normal errors and therefore find the optimal set 
of parameters by minimizing the sum of the squared differ-
ence between the model’s estimate for HIV prevalence and 
the HIV prevalence data. 
4 VALIDATION  
In the absence of data from the household survey, the 
model was validated by comparing its output with TB inci-
dence data for Zimbabwe and characteristics typical of 
epidemics of any infectious disease. We begin by consider-
ing the transitory behavior of the epidemic. 
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Figure 2: TB cases per 100,000 of population. 
 
 Figure 2 shows the average TB incidence output for 10 
runs of the model over a 300 year period. The number of 
TB cases can be seen to exhibit damped oscillations. 
Damped oscillations in the number of new infections are 
typical of the simple deterministic differential equation 
models often used to describe infectious disease epidemics, 
the so-called SIR models (SIR models are differential 
equation models with three states: susceptible, infected and 
recovered). In these models, the number of infections will 
then either stabilize at an endemic level or the epidemic 
dies out. The graph also shows the definite amplifying af-
fect of HIV on TB when it is introduced to the model dur-
ing the early 1980s. Obtaining behavior with these charac-
teristics from our stochastic model is encouraging.  
Figure 3 shows the observed TB incidence and HIV 
prevalence in Zimbabwe from 1980 onwards. HIV preva-
lence is increasing in Zimbabwe from 1984 and the num-
ber of TB cases shows a corresponding increase after a 
time lag of about 6 years, the time from initial HIV infec-
tion to developing late-stage HIV.   
 The corresponding model output is shown in Fig-
ures 4 and 5. Figure 4 shows the average model output for 
TB Incidence along with the output from 10 runs. The 
variability in the model estimates of TB incidence is due to 
the small number of individuals in the model population  
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Figure 3: TB incidence and HIV prevalence in Zimbabwe. 
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Figure 4: Model estimates of TB incidence in Zimbabwe. 
The graph shows the observed TB Incidence data from 
Zimbabwe and the output from 10 runs of the model, along 
with the average result. 
 
(10,000). The  increase in  the model’s  estimate of TB in-
cidence following the start of the HIV epidemic is obvious 
but is not pronounced enough and the steady state level of 
TB is currently too high. However, the results show that 
the model is reflecting the important interaction between 
the HIV and TB epidemics. 
 Figure 5 shows the average model output for HIV 
Prevalence along with the output from 10 runs. The output 
shows the model is accurately representing the HIV epi-
demic with little variability between runs. 
5 CONCLUSION 
We have described a model of TB and HIV that will be 
used to assess the effectiveness of different case detection 
strategies for TB. It should be stressed that this study is 
still in its early stages and so the results output by the 
model are provisional. We hope to have a more complete 
set of results ready in time for the conference in December. 
 The estimates of TB incidence output by the model 
exhibit a high variability. With populations of less than 
about 1000 people, the TB epidemic generally dies out.  4630%
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Figure 5: Model estimates of HIV Prevalence in Zim-
babwe. The graph shows the observed HIV Prevalence 
data from Zimbabwe and the output from 10 runs of the 
model, along with the average result. 
 
 Transmission of TB occurs with a relatively low prob-
ability and TB disease is relatively rare, therefore, these 
results are not surprising. As the model population is in-
creased, the proportion of runs in which the TB epidemic 
dies out decreases. Future iterations of the design could 
consider two options for the model: first use a model popu-
lation that is sufficiently large for TB disease to become 
endemic; or second include the effect of interactions of the 
model population with a background pool of TB infection. 
This background pool of TB infection should be represen-
tative of Zimbabwe as a whole and assumes the model 
population to be connected with the rest of the country 
rather than isolated from it.  
Many of the parameters used within the model will not 
change following the calibration of the model to the survey 
data. Those that will change include the distribution of 
household size, the magnitude of the HIV epidemic. Addi-
tional information coming from the survey will include the 
distribution of the population across the different TB and 
HIV disease states. This could be used for model validation 
or for setting the initial conditions. 
Experimentation within the model will focus on de-
termining strategies for reducing TB transmission by tar-
geting case-finding for TB disease. In its current form, ex-
perimentation with the model may be slow because of the 
small number of TB cases. The small number of transmis-
sion events will mean that a large number of runs will need 
to be made to obtain a reasonable level of variability. In 
situations such as this, importance sampling can often be 
used effectively as a variance reduction measure. This is 
something that we hope to investigate.  
We have begun with a simple method for transmis-
sion, differentiating only between transmission inside the 
household and transmission in the general community. De-
spite its simplicity this will still allow us to determine the 
significance of household versus community transmission 
and to analyze interventions targeted at household contacts 
of TB patients. Ultimately, we would like to use a geospa-
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tial model for transmissions, where transmission between 
people who live close to each other is more likely than 
transmission between people who live at opposite sides of 
the region being modeled. As well as making the model 
more accurate, this may also shed light on the effect of 
poverty (indicated by a high population density) on the 
clustering of TB cases. 
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